| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Development Officer | Chief Development Officer
2 companies
Tubridy Karen L serves as a SVP, Chief Development Officer at AKBA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $68K at current prices.
The biggest single holding is CARM (~$68K) as Chief Development Officer. The recent filings there lean toward selling, a net 8,799 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2020 | AKBA Akebia Therapeutics, Inc. | SVP, Chief Development Officer | Sell | 3,454 | $8.70 | $30,049.80 | -3.9% | |
| Jun 27, 2016 | CARM Carisma Therapeutics Inc. | Chief Development Officer | Sell | 4,372 | $2.08 | $9,093.76 | -11.8% | |
| Dec 28, 2015 | CARM Carisma Therapeutics Inc. | Chief Development Officer | Sell | 4,427 | $2.85 | $12,616.95 | -11.8% |